مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

89
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

59
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

Venlafaxine poisoning-induced severe hypoglycemia in a non-diabetic patient: a case report

Pages

  119-122

Abstract

 Introduction: Venlafaxine is a serotonin and norepinephrine reuptake inhibitor (SNRI) used to treat major depressive episodes and anxiety. The risk of hypoglycemia is mentioned in the Summary of Product Characteristics (SmPC) of Venlafaxine in the “ warnings and precautions” section in diabetic patients. This effect appears neither in the “ adverse reactions” nor in the “ overdose” section. We herein report a case of severe hypoglycemia with coma in relation to Venlafaxine poisoning. Case Report: A 35-year-old non-diabetic obese woman (BMI, 29 kg/m2) was found unconscious a few hours after ingesting Venlafaxine and bromazepam in a suicide attempt. Vital signs on day 1 were as follows: Glasgow Coma score of 7, blood pressure of 99/66 mmHg and heart rate of 100/min. Electrocardiogram showed no abnormality. She was admitted to the intensive care unit. Due to sustained hypoglycemia [0. 5 g/L (day1); 0. 41 g/L (day2); 0. 8 to 1. 20 (day3)], she received continuous intravenous 10% glucose infusion for 3 days to normalize blood glucose. Plasma Venlafaxine concentration was 11. 7 times the upper the limit of therapeutic dose range (UTDR) on day 2 and reached the therapeutic dose range (TDR) on day 6. Plasma bromazepam concentration was 6. 7 times UTDR on day 3 and reached TDR on day 8. Alternative etiologies of hypoglycemia were excluded, i. e. hypoglycemic sulfonamide, insulin poisoning, insulinoma, and disease of the adrenal gland, liver and thyroid. She was transferred to a psychiatric unit after one week. Discussion: Impairment of blood glucose homeostasis is rarely described with Venlafaxine. In our patient, hypoglycemia appeared to be correlated with plasma Venlafaxine concentrations and may be explained by increased insulin sensitivity, considering her obesity. Conclusion: Healthcare professionals should be aware of hypoglycemia induced by Venlafaxine or other SNRIs in non-diabetic patients.

Cites

  • No record.

    • References

    Cite

    APA: Copy

    SCHIESTEL, THOMAS. (2020). Venlafaxine poisoning-induced severe hypoglycemia in a non-diabetic patient: a case report. ASIA PACIFIC JOURNAL OF MEDICAL TOXICOLOGY (APJMT), 9(3), 119-122. SID. https://sid.ir/paper/664745/en

    Vancouver: Copy

    SCHIESTEL THOMAS. Venlafaxine poisoning-induced severe hypoglycemia in a non-diabetic patient: a case report. ASIA PACIFIC JOURNAL OF MEDICAL TOXICOLOGY (APJMT)[Internet]. 2020;9(3):119-122. Available from: https://sid.ir/paper/664745/en

    IEEE: Copy

    THOMAS SCHIESTEL, “Venlafaxine poisoning-induced severe hypoglycemia in a non-diabetic patient: a case report,” ASIA PACIFIC JOURNAL OF MEDICAL TOXICOLOGY (APJMT), vol. 9, no. 3, pp. 119–122, 2020, [Online]. Available: https://sid.ir/paper/664745/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button